Emergent BioSolutions
EBS
#6766
Rank
โ‚ฌ0.54 B
Marketcap
10,22ย โ‚ฌ
Share price
-1.24%
Change (1 day)
18.22%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚ฌ0.54 Billion

As of December 2025 Emergent BioSolutions has a market cap of โ‚ฌ0.54 Billion. This makes Emergent BioSolutions the world's 6766th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.54 B26.6%
2024โ‚ฌ0.43 B282.28%
2023โ‚ฌ0.11 B-79.49%
2022โ‚ฌ0.54 B-73.4%
2021โ‚ฌ2.06 B-46.51%
2020โ‚ฌ3.86 B55.06%
2019โ‚ฌ2.48 B-6.15%
2018โ‚ฌ2.65 B37.29%
2017โ‚ฌ1.93 B52.83%
2016โ‚ฌ1.26 B-12.32%
2015โ‚ฌ1.44 B70.79%
2014โ‚ฌ0.84 B38.48%
2013โ‚ฌ0.60 B40.17%
2012โ‚ฌ0.43 B-6.7%
2011โ‚ฌ0.46 B-24.5%
2010โ‚ฌ0.61 B111.15%
2009โ‚ฌ0.29 B-47.67%
2008โ‚ฌ0.55 B442.03%
2007โ‚ฌ0.10 B-55.83%
2006โ‚ฌ0.23 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Emergent BioSolutions was reported to be:

โ‚ฌ0.53 Billion
by Nasdaq info icon info icon
โ‚ฌ0.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚ฌ213.88 B 39,132.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ0.38 B-30.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.91 B 15,291.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ1.68 B 208.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ127.08 B 23,211.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.03 B 5,042.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚ฌ13.94 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA